TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia
Conditions
- Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
- Therapy-Related Acute Myeloid Leukemia
Interventions
- DRUG: Azacitidine
- DRUG: Dubermatinib
Sponsor
Uma Borate
Collaborators